OSAKA, Japan & SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen” TSE: 4536) and Glaukos Corporation (“Glaukos” NYSE: GKOS), announced today that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agr…
Author: Business Wire
Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
GENEVA–(BUSINESS WIRE)–Alcon to participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
GENEVA–(BUSINESS WIRE)–Alcon to participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
Eyenuk Will Announce Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System at ARVO Conference
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc. will release data from a pivotal clinical trial on EyeArt AI Eye Screening at ARVO in Vancouver, BC.
EnChroma Glasses Enhance O’Keeffe Museum Experience for Color Blind Visitors
SANTA FE, N.M. & BERKELEY, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/colorishere?src=hash" target="_blank"gt;#colorisherelt;/agt;–The Georgia O’Keeffe Museum and EnChroma® are partners on a…
Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting.
Allegro Ophthalmics Expands Its Anti-Integrin Portfolio with New Front-of-the-Eye Drug Candidate ALG-1007 for the Treatment of Dry Eye Disease
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ASCRS?src=hash" target="_blank"gt;#ASCRSlt;/agt;–Allegro Ophthalmics expands anti-integrin portfolio with new drug candidate ALG-1…
Global Ophthalmic Lens Market 2019-2023 – Expanding Applications of Bronchoscopy & Adoption of Refractive Vision Correction Surgeries – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Lens Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The analysts have predicted that the ophthalmic lens market will register a CAGR of almost 5% by 2023. The increasing initiatives for creating awareness about the benefits and advances in ophthalmic lenses are likely to drive the market’s growth in the forthcoming years. Several manufacturers are taking initiatives including the conduct of awareness and advertising
Novaliq and BLP Management Group Established New Company, Betaliq Inc., to Leverage EyeSol Technology to Treat Glaucoma
HEIDELBERG, Germany–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CyclASol?src=hash" target="_blank"gt;#CyclASollt;/agt;–Urgent. Fast approval would be appreciated.
Aerpio Pharmaceuticals to Present Data Demonstrating Role of VE-PTP in Conventional Outflow Homeostasis and the Potential of AKB-9778, a VE-PTP Inhibitor/Tie2 Activator, as a Treatment for Open-Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, will present data demonstrating the role of VE-…
Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-13503 Sustained Release Implant
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Ocular Therapeutix™ to Present New Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting and at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
Ocular Therapeutix™ Reports Changes to Board of Directors
BEDFORD, Mass–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&q…
Parkhurst NuVision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
SAN ANTONIO–(BUSINESS WIRE)–Parkhurst NuVision in San Antonio, Texas, is participating in the AcuFocus clinical study for the IC-8 intraocular lens designed for cataracts.
ProtoKinetix AAGP® in Phase 3 Retinal Replacement Program
MARIETTA, Ohio–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AAGP?src=hash" target="_blank"gt;#AAGPlt;/agt;–ProtoKinetix updates its stockholders regarding phase 3 of testing using AAGP® in retinal cell r…
Alcon to Host Trading Update for First Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Host Trading Update for First Quarter 2019 Results on Thursday, May 16, at 3:00 p.m. Central European Time/8 a.m. CDT
Alcon to Host Trading Update for First Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Host Trading Update for First Quarter 2019 Results on Thursday, May 16, at 3:00 p.m. Central European Time/8 a.m. CDT
Global Ophthalmology Therapeutics Market 2019-2023 – Key Players are Allergan, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, and Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The ophthalmology therapeutics market will register a CAGR of nearly 6% by 2023. The new drug approvals and strong drug pipeline will trigger the ophthalmology therapeutics market growth in the forthcoming years. Top players in the market are focusing on the development of disease-modifying drugs for treating the rising incidences of eye diseases. Further
Global $65 Billion Ophthalmic Devices Market: Major Deals, Trends, Key Players Analysis and Recent Developments (2012-2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Devices Market (By Applications, Products, End Users, Regions), Major Deals, Trends, Key Players Analysis, Recent Developments – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic devices market is predicted to reach nearly US$ 65 Billion by 2025. Ophthalmic devices are continuously gaining increased importance and adoption due to the high prevalence of various ophthalmic diseases such as glaucoma,
Physicians’ Education Resource® Hosts the 2019 New York Cardio-Endo-Renal Collaborative
CRANBURY, N.J.–(BUSINESS WIRE)–Physicians’ Education Resource® Hosts the 2019 New York Cardio-Endo-Renal Collaborative